Rapid Dose Therapeutics Completes Significant Shipment of QuickStrip™ Products to Thrive Cannabis
November 9, 2021
Rapid Dose Therapeutics Completes Significant Shipment of QuickStrip™ Products
to Thrive Cannabis
BURLINGTON, Ontario – November 9, 2021- Rapid Dose Therapeutics Corp. (“RDT” or the“Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, has completed a significant shipment of more than 500,000 QuickStrip™ units infused with Thrive Cannabis Inc.’s (“Thrive”) THC and CBD cannabis oils.
Currently sold in Ontario, Saskatchewan, Alberta, and British Columbia, RDT’s QuickStrips are sold under Thrive’s Being™ brand of THC and CBD 10mg oral strips.
“We continue to work collaboratively under agreement with a number of industry partners to bring QuickStrip™ cannabis products to market, which are quickly gaining in popularity within the recreational and medical markets as a result of their quick, convenient, precise, and discreet dosing experience,” said Mark Upsdell, CEO Rapid Dose Therapeutics. “We anticipate increased awareness of this novel delivery system will fuel the expansion of agreements with other leading cannabis brands.”
About Rapid Dose Therapeutics Corp.
Rapid Dose Therapeutics is a Canadian biotechnology company revolutionizing drug delivery through innovation. The Company’s flagship product QuickStrip™ is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient.
For more information:
|Mark Upsdell||Kim Robinson|
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS:
Certain information in this news release may contain forward-looking information within the meaning of applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as “may”, “should”, “anticipate”, “expect”, “potential”, “believe”, “intend”, “will”, “could”, “are planned to”, “are expected to” or the negative of these terms and similar expressions. Statements containing forward-looking information, including, without limitation, in respect of the delivery of equipment and products using the QuickStrip™ product delivery method, the generation of recurring revenues, as at the date of this news release, the plans, estimates, forecasts, projections, expectations or beliefs of RDT management as to future events or results and are believed to be reasonable based on information currently available to RDT management. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; termination of WLM agreements; future legislative and regulatory developments involving cannabis; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally, income tax and regulatory matters; the ability to implement its business strategies; competition; currency and interest rate fluctuations and other risks. Readers are cautioned that the foregoing list is not exhaustive. There can be no assurance that statements of forward-looking information, although considered reasonable by RDT management at the time of preparation, will prove to be accurate as there can be no assurance that the plans, intentions or expectations upon which they are based will occur. Actual results and future events could differ materially from those anticipated in such forward-looking statements. Readers should not place undue reliance on forward-looking statements. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.
Back to press releases page